SPY421.97-0.14 -0.03%
DIA338.65-2.11 -0.62%
IXIC14,161.35+121.67 0.87%

Biohaven Pharmaceutical Q1 Loss Widens, Revenue Rises; Shares Down Pre-Bell

05/10/2021 04:17

08:03 AM EDT, 05/10/2021 (MT Newswires) -- Biohaven Pharmaceutical Holding Company (BHVN) reported an adjusted net loss of $2.97 per share for Q1 of 2020, compared with a loss of $2.39 a year earlier. Analysts polled by Capital IQ expected a loss of $2.60 per share.

Revenue for the quarter ended March 31 for the biopharmaceutical company was $43.8 million, compared with $1.2 million in Q1 of 2020. The analysts' consensus forecast was for revenue of $43 million.

Shares of Biohaven Pharmaceutical are down nearly 2% in premarket trading.

Price: 70.25, Change: -1.19, Percent Change: -1.67